Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo

PHASE2CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

January 15, 2015

Primary Completion Date

September 18, 2017

Study Completion Date

October 9, 2017

Conditions
Alzheimer Disease
Interventions
DRUG

BI 409306

DRUG

Placebo

DRUG

BI 409306

DRUG

Placebo

DRUG

Placebo

DRUG

BI 409306

DRUG

BI 409306

DRUG

Placebo

DRUG

Placebo

Trial Locations (52)

1020

Brussels-UNIV Brugmann -Horta, Brussels

1130

Private Practice for Psychiatry and Neurology, Vienna

6060

Landeskrankenhaus Hall, Abt.f. Psychatrie & Psychotherapie A, Hall in Tirol

10245

Praxis Dr. med. Volker Schumann, Berlin

10312

Richmond Behavioral Associates, Staten Island

10629

emovis GmbH, Berlin

25123

A.O. Spedali Civili di Brescia, Brescia

26655

Neurologie und Psychiatrie / Psychotherapie, Westerstede

28270

ANI Neurology, PLLC, dba Alzheimer's Memory Center, Charlotte

28922

Hospital Universitario Fundación Alcorcón, Alcorcon (Madrid)

30120

Hospital Universitario Virgen de la Arrixaca, El Palmar (murcia)

33407

Premiere Research Institute, West Palm Beach

34295

HOP Gui de Chauliac, Montpellier

44093

HOP Nord Laënnec, Nantes

50143

Osp. S. Giovanni di Dio, Florence

68159

Zentralinstitut für seelische Gesundheit, Mannheim

69677

HOP Pierre Wertheimer, Bron

74104

Tulsa Clinical Research, LLC, Tulsa

75651

HOP La Pitié Salpêtrière, Paris

86021

HOP Jean Bernard, Géria, Poitiers, Poitiers

89081

Universitätsklinikum Ulm, Ulm

91403

California Neuroscience Research, Sherman Oaks

92868

Orange County Neuropsychiatric Research Center LLC, Orange

07724

Memory Enhancement Center of America, Inc., Eatontown

T2N 4Z6

University of Calgary, Calgary

V8R 1J8

Royal Jubilee Hospital, Victoria

B3S 1M7

True North Clinical Research Halifax, Inc., Halifax

B4B 4K9

True North Clinical Research Kentville, Inc., Kentville

M3B 2S7

Toronto Memory Program, Toronto

J1J 3H5

Institut universitaire de geriatrie Sherbrooke, Québec

04107

AFL Arzneimittelforschung Leipzig GmbH, Leipzig

00168

Policlinico Gemelli, Roma

1081 GN

Brain Research Center, Amsterdam

15-732

Podlassian Center of Psychogeriatry, Bialystok, Bialystok

85-796

"Non-Public Outpat. Clinic Dom Sue Ryder, PALLMED Sp. z o.o", Bydgoszcz

25-103

"Non-Public Outpatient Clinic Synapsa Pawel Polrola, Kielce", Kielce

25-411

Mental Health Center Biomed, Kielce

61-853

Non-Public Outpatient Clinic Neuro-Kard Ilkowski & Partners, Poznan

81-855

Medical Center Senior, Sopot

70-111

EUROMEDIS Sp. z o.o., Szczecin, Szczecin

51-124

Reg. Specialist Hospital Wroclaw, Research & Develop. Center, Wroclaw

2700-276

Hospital Fernando Fonseca, EPE, Amadora

3000-075

CHUC - Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra

1349-019

CHLO, EPE - Hospital Egas Moniz, Lisbon

1649-035

CHLN, EPE - Hospital de Santa Maria, Lisbon

08036

Hospital Clínic de Barcelona, Barcelona

08041

Hospital Santa Creu i Sant Pau, Barcelona

08190

Hospital Universitari General de Catalunya, Sant Cugat del Vallès

08221

Hospital Mútua Terrassa, Terrasa (Barcelona)

BA1 3NG

Royal United Hospital, Bath

PL21 9AB

Derriford Hospital, Plymouth

PL6 8BT

Re-Cognition Health, Plymouth

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02240693 - Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo | Biotech Hunter | Biotech Hunter